Patent · US Active

Nuclease-mediated nucleic acid modification

US12018297B2 · kind B2 · utility

0Cited by
4References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2019
Grant dateJun 25, 2024
Priority date
Expiry dateAug 28, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein is technology relating to molecular biological manipulation of genes and genomes and particularly, but not exclusively, to CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) methods, compositions, systems, and kits for improved genetic editing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.